{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:01:49Z","timestamp":1785801709632,"version":"3.56.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:00:00Z","timestamp":1767139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004789","name":"John Fell Fund, University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010438","name":"The Francis Crick Institute","doi-asserted-by":"publisher","award":["CC2223"],"award-info":[{"award-number":["CC2223"]}],"id":[{"id":"10.13039\/100010438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220549\/Z\/20\/Z"],"award-info":[{"award-number":["220549\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["110110\/Z\/15\/Z"],"award-info":[{"award-number":["110110\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012621","name":"NIHR UCLH BRC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcv.2025.105911","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:07:47Z","timestamp":1766794067000},"page":"105911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention"],"prefix":"10.1016","volume":"182","author":[{"given":"Joseph","family":"Mugisha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Kimono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila F.","family":"Lumley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Waddilove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Wekesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mgomella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Makanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Ndungutse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ponsiano","family":"Ocama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa C.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2025.105911_bib1","unstructured":"World Health Organization Hepatitis Factsheet: elimination of hepatitis by 2030. \u3008https:\/\/www.who.int\/health-topics\/hepatitis\/elimination-of-hepatitis-by-2030\u3009 (accessed July 6, 2024)."},{"key":"10.1016\/j.jcv.2025.105911_bib2","unstructured":"World Health Organization Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries. \u3008https:\/\/www.who.int\/publications\/i\/item\/9789240091672\u3009. ISBN: 978-92-4-009167-2, (accessed July 6, 2024)."},{"key":"10.1016\/j.jcv.2025.105911_bib3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.cmi.2016.07.035","article-title":"Hepatitis C: global epidemiology and strategies for control","volume":"22","author":"Lanini","year":"2016","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jcv.2025.105911_bib4","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/cid\/civ197","article-title":"Hepatitis C virus therapeutic development: in pursuit of \u201cperfectovir\u201d","volume":"60","author":"Dore","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105911_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/jvh.13467","article-title":"Risk factors for difficult-to-treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub-Saharan Africa","volume":"28","author":"Shumbusho","year":"2021","journal-title":"J. Viral Hepat."},{"issue":"6","key":"10.1016\/j.jcv.2025.105911_bib6","article-title":"European HCV resistance study group, rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients","author":"Dietz","year":"2024","journal-title":"JHEP Rep."},{"key":"10.1016\/j.jcv.2025.105911_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/v15030661","article-title":"The cascade of care for Hepatitis C treatment in Rwanda: a retrospective cohort study of the 2017-2019 mass screening and treatment campaign","volume":"15","author":"Nisingizwe","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.jcv.2025.105911_bib8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and treatment program to eliminate Hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcv.2025.105911_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003767","article-title":"Initial success from a public health approach to Hepatitis C testing, treatment and cure in seven countries: the road to elimination","volume":"5","author":"Boeke","year":"2020","journal-title":"BMJ Glob. Health"},{"key":"10.1016\/j.jcv.2025.105911_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ije\/dys234","article-title":"The General Population Cohort in rural south-western Uganda: a platform for communicable and non-communicable disease studies","volume":"42","author":"Asiki","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jcv.2025.105911_bib11","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/hep.30342","article-title":"Highly diverse Hepatitis C strains detected in sub-Saharan Africa have unknown susceptibility to direct-acting antiviral treatments","volume":"69","author":"Davis","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2025.105911_bib12","unstructured":"B. Kimono, P. Matthews, S. Lumley, E. Waddilove, M.K. Mbonye, R. Makanga, J. Mugisha, R. Newton, Uganda Liver Disease Study (ULiDS) - project summary 2023-2024, figshare, 2024."},{"key":"10.1016\/j.jcv.2025.105911_bib13","article-title":"Liver, cardiovascular and metabolic factors as predictors of all-cause mortality in a rural Ugandan Cohort","author":"Campbell","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/j.jcv.2025.105911_bib14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/hep.27950","article-title":"American Association for the Study of Liver Diseases and Infectious Diseases Society of America Hepatitis C Guidance Panel recommendations for testing, managing, and treating adults infected with hepatitis C Virus","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2025.105911_bib15","first-page":"1","article-title":"The HCV treatment revolution continues: resistance considerations, pangenotypic efficacy, and advances in challenging populations","volume":"12","author":"Jacobson","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2025.105911_bib16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S1473-3099(15)00157-7","article-title":"Ledipasvir and sofosbuvir for Hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study","volume":"15","author":"Kohli","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105911_bib17","unstructured":"M. Anderson, G. Sukali, J.-L. Upton, E. Waddilove, L. Downs, S. Lumley, M. Delphin, B. Kimono, J. Mugisha, J. Seeley, T. Khoza, S. Temmers, R. Newton, N. Mhlongo, V. Naidoo, P. Matthews, Elastography and CAP assessment for liver disease: training events and feedback representing clinical research programmes in South Africa, Uganda and Kenya, (2024)."},{"key":"10.1016\/j.jcv.2025.105911_bib18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1478-7954-9-36","article-title":"Using verbal autopsy to assess the prevalence of HIV infection among deaths in the ART period in rural Uganda: a prospective cohort study, 2006-2008","volume":"9","author":"Mayanja","year":"2011","journal-title":"Popul. Health Metr."},{"key":"10.1016\/j.jcv.2025.105911_bib19","article-title":"Liver function tests and fibrosis scores in a rural population in Africa: a cross-sectional study to estimate the burden of disease and associated risk factors","volume":"10","author":"O\u2019Hara","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcv.2025.105911_bib20","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4269\/ajtmh.19-0295","article-title":"A path to ending Hepatitis C in Ethiopia: a phased public health approach to achieve micro-elimination","volume":"101","author":"Taye","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jcv.2025.105911_bib21","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1038\/s41598-024-57013-1","article-title":"TAC ANRS12311 study group, feasibility, safety, efficacy and potential scaling-up of sofosbuvir-based HCV treatment in Central and West Africa: (TAC ANRS 12311 trial)","volume":"14","author":"Lacombe","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jcv.2025.105911_bib22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S2468-1253(18)30382-0","article-title":"Treatment of chronic Hepatitis C virus infection in Rwanda with ledipasvir-sofosbuvir (SHARED): a single-arm trial","volume":"4","author":"Gupta","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2025.105911_bib23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S2666-5247(24)00041-7","article-title":"Hepatitis C virus diversity and treatment outcomes in Benin: a prospective cohort study","volume":"5","author":"Ahov\u00e8gb\u00e9","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jcv.2025.105911_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2021.04.045","article-title":"Non-epidemic HCV genotypes in low- and middle-income countries and the risk of resistance to current direct-acting antiviral regimens","volume":"75","author":"Shah","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jcv.2025.105911_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2468-1253(21)00397-6","article-title":"A minimal monitoring approach for the treatment of Hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial","volume":"7","author":"Solomon","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2025.105911_bib26","unstructured":"World Hepatitis Alliance, The importance of Hepatitis B and C control and elimination. https:\/\/www.worldhepatitisalliance.org\/wp-content\/uploads\/2018\/06\/20170906_wha_hcvhbv_advocacy_final_update_edited_web_version.pdf. accessed December 4, 2025."},{"issue":"1","key":"10.1016\/j.jcv.2025.105911_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12913-021-07289-0","article-title":"Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa","volume":"22","author":"Boyer","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.jcv.2025.105911_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12879-023-08678-y","article-title":"Prevalence of Hepatitis B and C infection and linkage to care among patients with Non-Communicable Diseases in three rural Rwandan districts: a retrospective cross-sectional study","volume":"24","author":"Musafiri","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105911_bib29","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12879-019-4322-7","article-title":"Risk factors for viral Hepatitis C infection in Rwanda: results from a nationwide screening program","volume":"19","author":"Makuza","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jcv.2025.105911_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036711","article-title":"Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study","volume":"10","author":"Makuza","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcv.2025.105911_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0021853719001038","article-title":"Moving beyond colonial control? Economic forces and shifting migration from Ruanda-urundi to Buganda, 1920\u201360","volume":"60","author":"de Haas","year":"2019","journal-title":"J. Afr. Hist."},{"key":"10.1016\/j.jcv.2025.105911_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0287580","article-title":"Hepatitis C virus seroprevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study","volume":"18","author":"Nartey","year":"2023","journal-title":"PLoS One"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653225001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:07:17Z","timestamp":1777615637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653225001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":32,"alternative-id":["S1386653225001532"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105911","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Micro-elimination of Hepatitis C virus (HCV) infection in the General Population Cohort in rural Uganda: Long-term follow-up to assess feasibility and outcomes of a screening and treatment intervention","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2025.105911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105911"}}